株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

掻痒症:世界の治験動向

Pruritus Global Clinical Trials Review, H1, 2018

発行 GlobalData 商品コード 230751
出版日 ページ情報 英文 252 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
掻痒症:世界の治験動向 Pruritus Global Clinical Trials Review, H1, 2018
出版日: 2018年06月29日 ページ情報: 英文 252 Pages
概要

当レポートでは、世界各国における掻痒症の臨床試験について調査しており、地域・進捗状況・フェーズ(相)・募集状況別の実施件数や、代表的なスポンサー、開発中の治療薬の情報、各企業・機関での進行状況といった情報を提供しています。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:皮膚疾患治療薬の治験における掻痒症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:皮膚疾患治療薬の治験における掻痒症の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

掻痒症治療薬の治験に携わっている主要企業

有望な薬剤

治験プロファイルの概要

付録

図表

List of Tables

  • Pruritus Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Pruritus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Pruritus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
  • Pruritus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
  • Pruritus Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
  • Pruritus Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
  • Pruritus Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 13
  • Pruritus Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 14
  • Proportion of Pruritus to Dermatology Clinical Trials, G7 Countries (%), 2018* 15
  • Pruritus Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
  • Pruritus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
  • Proportion of Pruritus to Dermatology Clinical Trials, E7 Countries (%), 2018* 18
  • Pruritus Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
  • Pruritus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
  • Pruritus Therapeutics, Global, Clinical Trials by Phase, 2018* 21
  • Pruritus Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
  • Pruritus Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
  • Pruritus Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
  • Pruritus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
  • Pruritus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
  • Pruritus Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
  • Pruritus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
  • Pruritus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

List of Figures

  • Pruritus Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Pruritus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Pruritus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
  • Pruritus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
  • Pruritus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
  • Pruritus Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
  • Pruritus Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 13
  • Pruritus Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 14
  • Proportion of Pruritus to Dermatology Clinical Trials, G7 Countries (%), 2018* 15
  • Pruritus Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
  • Pruritus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
  • Proportion of Pruritus to Dermatology Clinical Trials, E7 Countries (%), 2018* 18
  • Pruritus Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
  • Pruritus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
  • Pruritus Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
  • Pruritus Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
  • Pruritus Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
  • Pruritus Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
  • Pruritus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
  • Pruritus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
  • Pruritus Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
  • Pruritus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
  • Pruritus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29
  • GlobalData Methodology 251
目次
Product Code: GDHC5044CTIDB

GlobalData's clinical trial report, "Pruritus Global Clinical Trials Review, H1, 2018" provides an overview of Pruritus clinical trials scenario. This report provides top line data relating to the clinical trials on Pruritus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Pruritus to Dermatology Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Pruritus to Dermatology Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Pruritus Therapeutics Clinical Trials 28
  • Prominent Drugs 29
  • Latest Clinical Trials News on Pruritus 30
  • May 21, 2018: Stanford Researchers Presented Results from an Exploratory Study of Serlopitant for the Treatment of Chronic Itch in Epidermolysis Bullosa Patients Indicating Reduction in Itch with Serlopitant Treatment 30
  • Apr 14, 2018: Albireo Reports Data on Pharmacodynamic Marker for A4250 in Children with Cholestatic Liver Disease at The International Liver Congress 2018 30
  • Apr 10, 2018: Cara Therapeutics Announces Participation in 2018 Spring Clinical Meetings of the National Kidney Foundation 31
  • Apr 08, 2018: Menlo Therapeutics Announces Results from a Phase 2 Trial of Serlopitant for Pruritus Associated with Atopic Dermatitis 31
  • Mar 28, 2018: Albireo to Present Clinical Data on A4250 at The International Liver Congress 2018 32
  • Clinical Trial Profile Snapshots 33

Appendix 250

  • Abbreviations 250
  • Definitions 250
  • Research Methodology 251
  • Secondary Research 251
  • About GlobalData 252
  • Contact Us 252
  • Source 252
Back to Top